Related Experiment Video
Updated: Jul 3, 2026

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro
Published on: March 17, 2023
5-Hydroxytryptamine 2A receptor signaling cascade modulates adiponectin and plasminogen activator inhibitor 1
Shoko Uchida-Kitajima1, Toshimasa Yamauchi, Youko Takashina
1Pharmacology Department II, Mitsubishi Tanabe Pharma Corporation, Toda-shi, Saitama 335-8505, Japan.
Abstract:
Knowledge of the regulatory factors associated with down-regulation of adiponectin gene expression and up-regulation of PAI-1 gene expression is crucial to understand the pathophysiological basis of obesity and metabolic diseases, and could establish new treatment strategies for these conditions. We showed that expression of 5-HT(2A) receptors was up-regulated in hypertrophic 3T3-L1 adipocytes, which exhibited decreased expression of adiponectin and increased expression of PAI-1. 5-HT(2A) receptor antagonists and suppression of 5-HT(2A) receptor gene expression enhanced adiponectin expression. Activation of Gq negatively regulated adiponectin expression, and inhibition of mitogen-activated protein kinase reversed the Gq-induced effect. Moreover, the 5-HT(2A) receptor blockade reduced PAI-1 expression. These findings indicate that antagonism of 5-HT(2A) receptors in adipocytes could improve the obesity-linked decreases in adiponectin expression and increases in PAI-1 expression.
Insights
Blocking 5-HT(2A) receptors in fat cells boosts adiponectin and lowers PAI-1. This finding offers potential new strategies for treating obesity and related metabolic diseases.
Area of Science:
- Cell Biology
- Metabolic Disease Research
- Pharmacology
Background:
- Obesity and metabolic diseases are linked to altered adiponectin and PAI-1 gene expression.
- Understanding regulatory factors is key for developing new therapeutic strategies.
Purpose of the Study:
- To investigate the role of 5-HT(2A) receptors in regulating adiponectin and PAI-1 expression in adipocytes.
- To explore potential therapeutic targets for obesity-related metabolic dysfunction.
Main Methods:
- Utilized hypertrophic 3T3-L1 adipocytes to study gene expression.
- Employed 5-HT(2A) receptor antagonists and gene expression suppression.
- Investigated the involvement of Gq signaling and mitogen-activated protein kinase pathways.
Main Results:
- 5-HT(2A) receptor expression was upregulated in hypertrophic adipocytes, correlating with decreased adiponectin and increased PAI-1.
- 5-HT(2A) receptor antagonism enhanced adiponectin expression and reduced PAI-1 expression.
- Gq activation negatively regulated adiponectin, an effect reversed by inhibiting mitogen-activated protein kinase.
Conclusions:
- Antagonism of 5-HT(2A) receptors in adipocytes can ameliorate obesity-associated changes in adiponectin and PAI-1 expression.
- Targeting 5-HT(2A) receptors presents a potential therapeutic avenue for metabolic diseases.
Related Concept Videos
cAMP-dependent Protein Kinase Pathways
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Regulation of Food Intake
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
GPCRs Regulate Adenylyl Cylase Activity
Two...
TGF - β Signaling Pathway

